📊 VSEEW Key Takeaways
Is Vsee Health, Inc.. (VSEEW) a Good Investment?
VSee Health is a financially distressed health services company with zero revenue growth, operating losses exceeding revenue (-$9.6M operating loss on $14.6M revenue), and negative free cash flow (-$3.5M). While the 50%+ gross margin indicates core unit economics could work, the company is burning cash rapidly with a critically weak liquidity position (0.51x current ratio) and limited runway without dramatic operational turnaround or capital infusion.
Why Buy Vsee Health, Inc.. Stock? VSEEW Key Strengths
- Solid gross margin of 50.3% suggests core business model viability if scaled efficiently
- Maintains $5.3M cash balance providing near-term operational runway
- Conservative capital expenditure approach minimizes discretionary cash burn
VSEEW Stock Risks: Vsee Health, Inc.. Investment Risks
- Zero revenue growth with operating losses of $9.6M exceeding total operating revenue
- Critical liquidity crisis: current ratio of 0.51x indicates insufficient current assets to cover liabilities
- Negative free cash flow of $3.5M annually with monthly burn rate threatening company viability within 12-18 months
Key Metrics to Watch
- Quarterly revenue growth rate and customer retention
- Operating cash flow improvement and path to positive cash operations
- Monthly cash burn rate and remaining runway before depletion
Vsee Health, Inc.. (VSEEW) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
VSEEW Profit Margin, ROE & Profitability Analysis
VSEEW vs Services Sector: How Vsee Health, Inc.. Compares
How Vsee Health, Inc.. compares to Services sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Vsee Health, Inc.. Stock Overvalued? VSEEW Valuation Analysis 2026
Based on fundamental analysis, Vsee Health, Inc.. shows some fundamental concerns relative to the Services sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Vsee Health, Inc.. Balance Sheet: VSEEW Debt, Cash & Liquidity
VSEEW Revenue & Earnings Growth: 5-Year Financial Trend
5-Year Trend Summary: Vsee Health, Inc..'s revenue has grown significantly by 40% over the 5-year period, indicating strong business expansion. The most recent EPS of $-5.65 indicates the company is currently unprofitable.
VSEEW Revenue Growth, EPS Growth & YoY Performance
VSEEW Quarterly Earnings & Performance
| Quarter | Revenue | Net Income | EPS |
|---|---|---|---|
| Q3 2025 | $3.4M | -$289.7K | $-0.02 |
| Q2 2025 | $1.7M | -$571.4K | $-0.11 |
| Q1 2025 | $1.6M | $62.8K | $0.01 |
| Q3 2024 | $1.5M | -$2.8K | $-0.01 |
| Q2 2024 | $1.3M | -$2.8K | $-0.06 |
Data sourced from SEC EDGAR 10-Q quarterly filings. Figures may represent quarterly or cumulative values.
Vsee Health, Inc.. Dividends, Buybacks & Capital Allocation
VSEEW SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Vsee Health, Inc.. (CIK: 0001864531)
📋 Recent SEC Filings
❓ Frequently Asked Questions about VSEEW
What is the AI rating for VSEEW?
Vsee Health, Inc.. (VSEEW) has an AI rating of STRONG SELL with 90% confidence, based on fundamental analysis of SEC EDGAR filings.
What are VSEEW's key strengths?
Claude: Solid gross margin of 50.3% suggests core business model viability if scaled efficiently. Maintains $5.3M cash balance providing near-term operational runway.
What are the risks of investing in VSEEW?
Claude: Zero revenue growth with operating losses of $9.6M exceeding total operating revenue. Critical liquidity crisis: current ratio of 0.51x indicates insufficient current assets to cover liabilities.
What is VSEEW's revenue and growth?
Vsee Health, Inc.. reported revenue of $14.6M.
Does VSEEW pay dividends?
Vsee Health, Inc.. does not currently pay dividends.
Where can I find VSEEW SEC filings?
Official SEC filings for Vsee Health, Inc.. (CIK: 0001864531) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is VSEEW's EPS?
Vsee Health, Inc.. has a diluted EPS of $-0.73.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined rating reflects both perspectives for balanced insights.
Is VSEEW a good stock to buy right now?
Based on our AI fundamental analysis in April 2026, Vsee Health, Inc.. has a STRONG SELL rating with 90% confidence. Review the strengths and risks sections above before making a decision. This is not investment advice.
Is VSEEW stock overvalued or undervalued?
Valuation metrics for VSEEW: ROE of -269.8% (sector avg: 16%), net margin of -100.6% (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
Should I buy VSEEW stock in 2026?
Our dual AI analysis gives Vsee Health, Inc.. a combined STRONG SELL rating for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is VSEEW's free cash flow?
Vsee Health, Inc..'s operating cash flow is $-3.4M, with capital expenditures of $29.9K. FCF margin is -23.8%.
How does VSEEW compare to other Services stocks?
Vs Services sector averages: Net margin -100.6% (avg: 10%), ROE -269.8% (avg: 16%), current ratio 0.51 (avg: 1.5).